Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas

被引:24
作者
Kurotani, R
Yasuda, M
Oyama, K
Egashira, N
Sugaya, M
Teramoto, A
Osamura, RY [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Pathol, Isehara, Kanagawa 2591193, Japan
[2] Nippon Med Coll, Dept Neurosurg, Tokyo 113, Japan
关键词
gp80; gp130; human pituitary adenoma; human pituitary gland; IL-6; immunohistochemistry;
D O I
10.1038/modpathol.3880392
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Interleukin-6 (IL-6) is an important cytokine in cen proliferation and differentiation in several organs. It has also been reported that IL-6 plays a role in secretion or release of pituitary hormones in pituitary hormone-secreting cells and pituitary adenomas, but convincing data in situ have not yet been reported. In this study, we examined the participation of IL-6 in the production of pituitary hormones and the differences between human normal pituitary glands and pituitary adenomas by determination of the localization or expression of IL-6, IL-6 receptor (IL-6R, gp80), and the signal-transducing subunit (gp130) of the receptor using immunohistochemical staining and RT-PCR. IL-6 was mainly expressed in ACTH- and FSH/LH-secreting cells in normal pituitary glands, as shown by double staining. gp 80 and gp130 were coexpressed in almost all GH- and PRL-secreting cells and in approximately 30% of FSH/LH-secreting cells. RT-PCR showed that IL-6 mRNA was expressed in only one of all the pituitary adenomas examined, whereas gp 80 and gp 130 mRNAs were detected in all these pituitary adenomas. In conclusion, IL-6 was mainly expressed in ACTH- and FSH/LH-secreting cells, and the receptors were expressed in GH-, PRL- and FSH/LH-secreting cells in human normal pituitary glands. Furthermore, our data emphasized that the mechanism of IL-6 function in human pituitary adenoma cells is distinct from that in normal pituitary cells.
引用
收藏
页码:791 / 797
页数:7
相关论文
共 23 条
[1]   INTERLEUKIN-6 IN BIOLOGY AND MEDICINE [J].
AKIRA, S ;
TAGA, T ;
KISHIMOTO, T .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :1-78
[2]   Heterogeneity of pituitary folliculo-stellate cells: Implications for interleukin-6 production and accessory function in vivo [J].
Allaerts, W ;
Jeucken, PHM ;
Debets, R ;
Hoefakker, S ;
Claassen, E ;
Drexhage, HA .
JOURNAL OF NEUROENDOCRINOLOGY, 1997, 9 (01) :43-53
[3]   Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis [J].
Barkhudaryan, N ;
Dunn, AJ .
NEUROCHEMICAL RESEARCH, 1999, 24 (09) :1169-1180
[4]   Immune-neuro-endocrine interactions: Facts and hypotheses [J].
Besedovsky, HO ;
DelRey, A .
ENDOCRINE REVIEWS, 1996, 17 (01) :64-102
[5]   EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-1-ALPHA, INTERLEUKIN-1-BETA, 2 AND 6 ON ACTH SYNTHESIS AND RELEASE IN THE MOUSE PITUITARY-TUMOR CELL-LINE ATT-20 [J].
FUKATA, J ;
USUI, T ;
NAITOH, Y ;
NAKAI, Y ;
IMURA, H .
JOURNAL OF ENDOCRINOLOGY, 1989, 122 (01) :33-39
[6]   Role of interleukin-6 in the pathogenesis of multiple myeloma [J].
Gadó, K ;
Domján, C ;
Hegyesi, H ;
Falus, A .
CELL BIOLOGY INTERNATIONAL, 2000, 24 (04) :195-209
[7]  
GANDOUREDWARDS R, 1995, MODERN PATHOL, V8, P160
[8]   Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats [J].
Graf, MR ;
Merchant, RE .
JOURNAL OF NEURO-ONCOLOGY, 1999, 45 (03) :209-218
[9]   IL-6 type cytokine receptor complexes:: Hexamer, tetramer or both? [J].
Grötzinger, J ;
Kernebeck, T ;
Kallen, KJ ;
Rose-John, S .
BIOLOGICAL CHEMISTRY, 1999, 380 (7-8) :803-813
[10]   Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway [J].
Heinrich, PC ;
Behrmann, I ;
Müller-Newen, G ;
Schaper, F ;
Graeve, L .
BIOCHEMICAL JOURNAL, 1998, 334 :297-314